North America OTC Drug and Dietary Supplement Market Growth and Forecast by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North America OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Cough and Cold Products, Vitamins and Dietary Supplements, Analgesics, Gastrointestinal Products, Sleep Aids, Oral Care Products, Ophthalmic Products, Antacids, Feminine Care, and Others); Type (Branded and Generic); Form (Tablets, Capsules, Powders, Ointments, Liquid, and Others); Distribution Channel (Hospital and Retail Pharmacies, Retail Stores, Online Channels, and Others), and Geography

Report Date : Sep 2020
Report Code : TIPRE00013996

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 198

Page Updated: Sep 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The North America OTC Drug and Dietary Supplement market was valued at US$ 131,818.3 million in 2019 and is projected to reach US$ 224,349.5 million by 2027; it is expected to grow at a CAGR of 7.0% during 2020–2027.

The growth of the OTC Drug and Dietary Supplement market is mainly attributed to the factors such as as rising awareness among population about general health issues, and advantages of OTC drugs are expected to propel the growth of the market. However, strict FDA regulation for OTC drugs is the major factor hindering the market growth.

The US has observed the fastest growth in the OTC Drug and Dietary Supplement market within the past few years and is expected to lead the market in North America during the forecast period. The country is the largest producer of pharmaceutical products and is a leading country for producing innovative drugs. Therefore, OTC drugs, prescribed drugs, and dietary supplements play a significant role in the US's healthcare system. The largest-selling OTC drug class in the US is upper respiratory remedies, oral analgesics, heartburn, antiperspirants, oral antiseptics and rinses, first aids, and beauty products.

US OTC Drug and Dietary Supplement Market Revenue and Forecast to 2027 (US$ Million)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

NORTH AMERICA OTC DRUG AND DIETARY SUPPLEMENT – MARKET SEGMENTATION

OTC drug and Dietary Supplement – By Product

Cough and Cold Products
Vitamins and Dietary Supplements
Analgesics
Gastrointestinal Products
Sleep Aids
Oral Care Products
Ophthalmic Products
Antacids
Feminine Care
Others

OTC Drug and Dietary Supplement– By Type

Branded
Generic

OTC Drug and Dietary Supplement– By Form

Tablets
Capsules
Powders
Ointments
Liquid
Others

OTC Drug and Dietary Supplement – By Distribution Channel

Hospital and Retail Pharmacies
Retail Stores
Online Channels
Others

By Country

US
Canada
Mexico

Company Profiles

GlaxoSmithKline plc.
Sanofi
Johnson and Johnson Services, Inc.
Abbott
AbbVie Inc.
Bausch Health Companies Inc.
Bayer AG
Procter & Gamble
Novartis AG
Reckitt Benckiser Group Plc

North America OTC Drug and Dietary Supplement Report Scope

Report Attribute	Details
Market size in 2019	US$ 131,818.3 Million
Market Size by 2027	US$ 224,349.5 Million
Global CAGR (2020 - 2027)	7.0%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Product Cough and Cold Products Vitamins and Dietary Supplements Analgesics Gastrointestinal Products Sleep Aids Oral Care Products Ophthalmic Products Antacids Feminine Care By Type Branded and Generic By Form Tablets Capsules Powders Ointments Liquid By Distribution Channel Hospital and Retail Pharmacies Retail Stores Online Channels
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	GlaxoSmithKline plc. Sanofi Johnson and Johnson Services, Inc. Abbott AbbVie Inc. Bausch Health Companies Inc. Bayer AG Procter & Gamble Novartis AG

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America OTC Drug and Dietary Supplement Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy